Clinical trial
Assessing Targeted Fluid Resuscitation Strategies Among Patients With Severe Sepsis and Septic Shock
NCT03137446 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing Targeted Fluid Resuscitation Strategies Among Patients With Severe Sepsis and Septic Shock
- Lead sponsor
- Rhode Island Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 20, 2017
- Completion date
- March 30, 2018
- Enrollment
- 113 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock, severe sepsis